A team of researchers at the University of New Mexico (UNM) and the National Institutes of Health (NIH) have developed a vaccine to treat high cholesterol. The vaccine, which targets a molecule called PCSK9, a protein involved in cholesterol metabolism, is a cost-effective alternative to current expensive cholesterol drugs and could lead to a widely applicable vaccine-based approach for controlling high cholesterol and cardiovascular disease.
The study demonstrated that the vaccine dramatically lowered cholesterol levels in animals. The study, “A Cholesterol-Lowering VLP Vaccine that Targets PCSK9,” was recently published in the journal Vaccineby Dr. Bryce Chackerian, professor in the Department of Molecular Genetics & Microbiology at UNM, Erin Crossey, an MD/Ph.D. student at UNM, and Drs. Alan Remaley, John Schiller and Marcelo Amar at NIH.
Genetic mutations that increase PCSK9 activity are linked to increased levels of low-density lipoprotein cholesterol (LDL-C—the “bad” cholesterol), which in turn is associated with an increased risk of plaque build-up in the arteries leading to coronary heart disease (CHD) and stroke. More than 73 million adults in the United States (approximately 32 percent of the population) have elevated LDL-C levels, or high cholesterol.
Although lifestyle changes and medication (such as statins) can lower LDL-C, more than 60 percent of at-risk patients on lipid lowering therapy still go on to have a cardiovascular event.
Statins have side effects, including increased concentrations of liver enzymes, muscle pain, cognitive loss, increased risk of diabetes, and adverse drug interactions. As an alternative to statins, drug companies have developed monoclonal antibody-based drugs that target PCSK9, such as Alirocumab and Evolocumab that were recently approved by the FDA to treat high cholesterol.
While these drugs have been shown to dramatically reduce LDL-C levels (by up to 60 percent) and cardiovascular events, they are extremely expensive, costing over $10,000 per year. This will likely limit the use of this class of drugs for those patients who cannot be effectively managed with statins or some of the other currently used cholesterol-lowering drugs. Additionally, monoclonal antibody therapies must be administered repeatedly for therapeutic effect.
The vaccine uses a VLP (virus-like particle) technology developed by Dr. Chackerian and his UNM co-inventors as an immunogenic carrier of an antigenic PCSK9 peptide. VLP’s are viruses that have had their DNA removed so that they retain their external structure for antigen display but are unable to replicate; they can induce an immune response without causing infection. VLP based vaccines are effective and safe and can be developed rapidly at low cost.
In the study, mice and macaques vaccinated with bacteriophage VLPs displaying PCSK9-derived peptides developed high titer IgG antibodies that bound to circulating PCSK9. Vaccination was associated with significant reductions in total cholesterol, free cholesterol, phospholipids, and triglycerides.
“We believe that this vaccine could lead to a widely applicable approach for controlling hypercholesteremia and cardiovascular disease,” Chackerian said.
Read more: UNM, NIH researchers develop vaccine to treat high cholesterol
The Latest on: High cholesterol
via Google News
The Latest on: High cholesterol
- Pecan-enriched diet shown to reduce cholesterolon August 23, 2021 at 9:20 am
While the proper pronunciation of pecan remains a subject of debate, University of Georgia researchers have shown the tree nut can dramatically improve a person's cholesterol levels.
- How to live longer: The cholesterol-lowering fruit that could ward off high blood pressureon August 23, 2021 at 9:14 am
HIGH blood pressure and high cholesterol are often found operating in conjunction with one another. When left untreated, both conditions can set the stage for serious heart complications, making them ...
- High cholesterol symptoms: The telling sign when exercising of the conditionon August 23, 2021 at 5:46 am
HIGH cholesterol can cause problems with the heart and circulatory system. In time, the life-threatening condition can lead to a heart attack or stroke.
- My High Cholesterol Caused a Rare Type of Heart Attack Days After I Gave Birthon August 20, 2021 at 6:27 am
She was young, fit, and healthy. But eight days after giving birth, she had a rare type of heart attack called spontaneous coronary artery dissection, which was caused by undiagnosed high cholesterol.
- U.S. government poised to withdraw longstanding warnings about cholesterolon August 20, 2021 at 3:46 am
The nation’s top nutrition advisory panel has decided to drop its caution about eating cholesterol-laden food, a move that could undo almost 40 years of government warnings about its consumption. The ...
- My Doctor Told Me Not To Worry About My High Cholesterol—and I Ended Up Needing a Quadruple Bypasson August 19, 2021 at 5:14 am
Here's how one woman found a treatment for her genetic high cholesterol after a healthy lifestyle, statins, and a controversial heart test didn't help. The post My Doctor Told Me Not To Worry About My ...
- Hartford Healthcare doctor explains what cholesterol is, how it can negatively impact your lifeon August 18, 2021 at 10:17 am
Tens of millions of Americans across the United States have high cholesterol, but not all of them are getting the proper treatment. So, what is cholesterol and how can it negatively impact your ...
- Your Secret Cholesterol-Lowering Weaponon August 16, 2021 at 1:03 pm
Want to improve your heart health and lower your cholesterol? Experts explain how upping your fiber intake may do the trick.
- Doctor’s Tip: Food as medicine for chronic kidney disease and high cholesterol — a patient storyon August 12, 2021 at 5:26 pm
The two kidneys are the shape of beans but much larger. Around 1 million microscopic filters in each kidney get rid of waste products in the blood, via urine. In addition to glomeruli, kidneys ...
- Cholesterol-lowering drug being tested at Penn Medicine to help fight COVID-19on August 10, 2021 at 7:38 pm
Cardiologist Dr. Julio Chirinos is leading the trial at Penn Medicine, testing to see if the drug commonly known as Tricor can help patients battling COVID-19. Lab studies show it ...
via Bing News